Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
skin irritation: in vitro / ex vivo
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2017-08-30 to 2017-09-01
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study
Remarks:
GLP guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2017
Report date:
2017

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
other: EU Method B.46 (Skin Irritation)
Version / remarks:
July 2012
Deviations:
no
Qualifier:
according to guideline
Guideline:
other: OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method
Version / remarks:
July 2015
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Remarks:
Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit, München, Germany

Test material

Constituent 1
Chemical structure
Reference substance name:
Trisodium 5,5'-[(2-sulphonato-1,4-phenylene)bis(azo)]bis(salicylate)
EC Number:
276-501-5
EC Name:
Trisodium 5,5'-[(2-sulphonato-1,4-phenylene)bis(azo)]bis(salicylate)
Cas Number:
72230-95-6
Molecular formula:
C20H14N4O9S.3Na
IUPAC Name:
trisodium 3,3'-[(2-sulfonato-1,4-phenylene)didiazene-2,1-diyl]bis(6-hydroxybenzoate)

In vitro test system

Test system:
human skin model
Justification for test system used:
Recommended in vitro model
Vehicle:
unchanged (no vehicle)
Remarks:
distilled water was applied to the epidermal surface in order to improve further contact between the powder and the epidermis
Details on test system:
Dose Groups
1. Negative control 10 µL DPBS
2. Positive control 10 µL 5% SDS solution
3. Test Item 10 ± 2 mg + 5 µL aqua dest.
The test was performed on a total of 3 tissues per dose group.
SDS sodium dodecyl sulfate
DPBS Dulbecco's phosphate buffered saline
Control samples:
yes, concurrent vehicle
yes, concurrent positive control
Amount/concentration applied:
10 ± 2 mg + 5 µL aqua dest.
Duration of treatment / exposure:
15 minutes
Duration of post-treatment incubation (if applicable):
42 +/- 1 h
Number of replicates:
3

Test system

Details on study design:
The test was performed on EpiSkin, an organotypic reconstructed three-dimensional model of the human epidermis. 3 replicate tissues are dosed with the test
item, the negative control (10µL DPBS) and the positive control (10µL 5% SDS), respectively. After 15 minutes treatment period at room temperature the test item and the controls are rinsed off with DPBS and the tissues are post-incubated for 42 +/- 1 h. Then the tissues are stained via MTT for 3 hours. Isopropanol
extracts are measured photometrically at 570 nm.

Results and discussion

In vitro

Results
Irritation / corrosion parameter:
% tissue viability
Value:
96.9
Vehicle controls validity:
valid
Negative controls validity:
valid
Positive controls validity:
valid
Remarks on result:
no indication of irritation
Other effects / acceptance of results:
Test Acceptance Criteria
Value Cut off pass/fail
Mean OD570 nm Blank 0.043 < 0.1 pass
Mean Absolute OD570 nm NK 0.950 0.6 ≤ NK ≤1.5 pass
Mean Relative Viability [%] PC 17% ≤ 40% pass
SD of % Viability [%] 4.2% - 12.1% ≤ 18% pass

Any other information on results incl. tables

The mixture of 10 mg test item per 2 mL MTT medium showed no reduction of MTT as compared to the solvent. The mixture did not turn blue/purple. Therefore, NSMTT equalled 0%. 

The mixtures of 10 mg of the test item per 90 µL aqua dest. and per 90 µL isopropanol showed colouring detectable by unaided eye-assessment and the chemical in water and isopropanol absorbed light in the range of 570 ± 30 nm. Therefore, the non-specific colour (NSCliving) was determined and calculated according to the following formula:

NSCliving[%] = [ODTVT/ODNK]*100 = [0.0103/0.907]*100 = 1.1%

NSCliving was ≤ 5% (1.1%) relative to the negative control of living epidermis. No correction of results was necessary.

Result of the Test Item

Name

Negative Control

Positive Control

Test Item

Tissue

1

2

3

1

2

3

1

2

3

Absolute OD570

0.931

0.905

0.990

0.108

0.157

0.308

0.857

0.892

0.977

0.958

0.924

0.991

0.116

0.158

0.334

0.885

0.920

0.999

OD570(Blank-Corrected)

0.888

0.862

0.947

0.065

0.114

0.265

0.814

0.849

0.934

0.915

0.881

0.948

0.073

0.115

0.291

0.842

0.877

0.956

Mean OD570Of The Duplicates (Blank-Corrected)

0.902

0.871

0.948

0.069

0.115

0.278

0.828

0.863

0.945

 Total Mean OD570Of 3 Replicate Tissues (Blank-Corrected)

0.907*

0.154

0.878

SD OD570

0.038

0.110

0.060

Relative Tissue Viabilities [%]

99.4

96.1

104.5

7.6

12.6

30.7

91.3

95.1

104.2

Mean Relative Tissue Viability [%]

100.0

17.0**

96.9

SD Tissue Viability [%]***

4.2

12.1

6.6

CV [% Viability]

4.2

71.6

6.8

*        Corrected mean OD570 of the negative control corresponds to 100% absolute tissue viability.

**       Mean relative tissue viability of the three positive control tissues is  40%.

***      Standard deviation (SD) obtained from the three concurrently tested tissues is  18%.

The mean tissue viabilities are calculated relatively to the mean of the negative controls.

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Remarks:
Regulation (EC) no 1272/2008
Conclusions:
In this study under the given conditions the test item showed no irritant effects. The relative mean tissue viability after 15 min of exposure and 42 h post-incubation was > 50%. The test item is therefore classified as “non-irritant” in accordance with UN GHS “No Category”.
Executive summary:

In the present study the skin irritant potential of the test itemwas analysed. The EPISKIN-Standard Model™ (EPISKIN-SMTM), a reconstituted three-dimensional human epidermis model, was used as a replacement for the Draize Skin Irritation Test (OECD TG 404[8]). Hereby, the test item was applied topically. Cytotoxicity is expressed as the reduction of mitochondrial dehydrogenase activity measured by formazan production from MTT after a 15 min exposure and 42 h post-incubation period and compared to those of the concurrent negative controls.

The test item showed no non-specific MTT-reducing potential but it showed colouring potential after mixture with aqua dest. or isopropanol, which did not influence the validity of the study. NSCliving was determined to 1.1%, therefore no correction of results was necessary.

The test item showed no irritant effects. The mean relative tissue viability (% negative control) was > 50% (96.9%) after 15 min treatment and 42 h post-incubation. The test item is therefore classified as “non-irritant” in accordance with UN GHS “No Category”.